SITC Archive Library

Presentation slides and video from the 2023 Advances in Cancer Immunotherapy^™ Series: A Focus on Pediatric Cancers were presented virtually on May 3, 2023.

Program Organizers

• Erica Braverman, MD – University of Pittsburgh
• Christian Capitini, MD – University of Wisconsin–Madison
  
• John A. Ligon, MD – University of Florida
  
  

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Program Learning Objectives

• Identify the cancer immunotherapy approaches in use for the treatment of pediatric cancers.
• Summarize recent updates in cancer immunotherapy for pediatric cancers and toxicity management for key disease states.
• Implement cancer immunotherapy for pediatric cancers into clinical practice appropriately.
  
  

You can view the program agenda here.

Please note on-demand recordings are not available for continuing education credits.